- How You Can Help Prevent Suicide During the COVID-19 Pandemic
- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
- Conspiracy Theories Are Helping Fuel Rejection of Masks, Vaccines
- U.S. Coronavirus Cases Top 7 Million
- Health Highlights: Sept. 25, 2020
- After COVID-19 Exposure, When Can Young Athletes Resume Play?
- Kids Who Need Steroids Face Risk of Diabetes, Other Ills
- COVID Bites: Cracked Teeth Another Coronavirus Scourge
Clinical Trials Update: July 22, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Rheumatoid Arthritis
This study of an investigational drug is for people who now take Methotrexate for rheumatoid arthritis.
The research site is in Worcester, Mass.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/rheumatoid_arthritis.aspx.
—–
Pediatric Migraine
This study will evaluate an investigational drug to treat migraines in children. Participants must be between 12 and 17 and have had migraines for at least six months.
The research site is in Duluth, Ga.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.
—–
Type 2 Diabetes
If you qualify for this type 2 diabetes study, you will receive study medication and study-related health evaluations at no cost, and possible reimbursement for time and travel.
The research site is in Scarborough, Maine.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
